FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for NOVOLIN N (human insulin) submitted by Novo Nordisk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• NOVOLIN N (HUMAN INSULIN)

Snippet

SUPPL AP for NOVOLIN N (HUMAN INSULIN)